This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Memory & Learning Stack
Cognition / Memory Encoding / Learning Retention / Beginner-Friendly Nootropic Stack
Overview
What is Memory & Learning Stack?
Scientific Sean's beginner-friendly nootropic stack oriented around 'learning and retaining information.' Pairs a choline foundation (CDP-Choline) with one synaptogenic peptide (Dihexa) and one or two racetams (Piracetam plus either Nefiracetam or Oxiracetam), with optional Paraxanthine for energy. Sean explicitly frames this as RUO (research use only) — a community/forum protocol, not a clinically validated regimen, but built around a coherent mechanistic logic: supply the substrate (choline) → drive plasticity (Dihexa) → enhance neurotransmission and memory encoding (racetams) → optionally add clean stimulation (paraxanthine).
Key Benefits
Stronger memory encoding and verbal recall, faster learning curve on new material, improved mental train-of-thought and processing speed, reduced brain fog, and better synaptic plasticity for long-term retention. Reported gains are gradual and cumulative over weeks rather than acute hits — the racetam + choline base typically produces a noticeable subjective lift by week 1-2, while Dihexa's synaptogenic effects accumulate across a 4-8 week cycle.
Mechanism of Action
Layered cognitive stack converging on memory and learning from four mechanistic angles. CDP-Choline supplies the choline substrate for acetylcholine synthesis (memory, focus, mental clarity) and replenishes the pool that racetams deplete. Dihexa is an HGF-mimetic that drives synaptogenesis, dendritic spine formation, and long-term potentiation through c-met signaling. Piracetam modulates NMDA, cholinergic, and glutamatergic signaling and increases brain energy production. Nefiracetam potentiates α4β2 nicotinic receptors, modulates NMDA glycine-site signaling, and reduces the magnesium block via PKC for stronger LTP; Oxiracetam (the alternative) boosts acetylcholine signaling and enhances AMPA/NMDA glutamate activity for faster, more logical processing. Paraxanthine (caffeine's main active metabolite) provides cleaner adenosine-receptor-driven stimulation without the peripheral push of caffeine.
What to Expect
- Week 1Tolerability and dose-response.
- Week 2-4Early effect window.
- Week 4-8Peak benefit assessment.
- Week 8+Cycle decision point.
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.